← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2009Last known activity
Aug 23, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT05186415Reponsible party - principal investigatorPhase 1/Phase 2Aug 23, 2022
- NCT05186415Lead sponsorPhase 1/Phase 2Aug 23, 2022
- NCT04200313OfficialN/AMar 31, 2020
- NCT04200313Overall official - principal investigatorN/AMar 31, 2020
- NCT02947100Lead sponsorPhase 1/Phase 2Jan 1, 2017
- NCT03199638Overall official - principal investigatorN/AApr 30, 2016
- NCT00915902Lead sponsorPhase 2/Phase 3Jul 1, 2009
Details
- Last known activity
- Aug 23, 2022